NEUP · Neuphoria Therapeutics Inc.
Market Cap
$20.32M
Shares
5.40M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Diluted EPS
-$0.23
+98.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $16.75M | $16.78M | $17.89M | $21.98M | — | — | — | |
| -$16.76M | -$1.13M | -$17.89M | -$21.98M | — | — | — | |
| AUD | — | — | — | 29.23K | 44.17K | 1.44M | 1.85M |
| $582.52K | $166.5K | $220.1K | $323.16K | — | — | — | |
| -$1.04M | $291.09K | $2.31M | $462.13K | — | — | — | |
| -$15.59M | -$201.1K | -$15.45M | -$22.42M | — | — | — | |
| USD/shares | -$9.02 | -$0.23 | -$18.62 | -$0.24 | — | — | — |
| USD/shares | -$9.64 | -$0.23 | -$18.62 | -$0.24 | — | — | — |
| shares | — | 1.62M | 832.23K | 122.39M | — | — | — |
| shares | — | 1.62M | 832.23K | 122.39M | — | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts
CIK
1191070
CUSIP
64136E102
13F (30d)
20 filings
20 filers
Visit website
Investor relations